Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001731122-18-000140)

Filing Details

Accession Number:: 0001731122-18-000140
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-11-07 21:13:08
Reporting Period:: 2018-05-21

Accepted Time:: 2018-11-07 21:13:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1527728	Enochian Biosciences Inc	ENOB	Pharmaceutical Preparations (2834)	452259340

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1709513	Rene Sindlev	Stumpedyssevej 17 Copenhagen G7 2100		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-05-21	1,300	$5.38	5,022,169	No	4	P	Indirect	By RS Group ApS

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By RS Group ApS

Footnotes

On May 21, 2018, RS Group ApS, an entity controlled by Mr. Sindlev, purchased 1,300 shares of common stock of Enochian Biosciences, Inc. in an open market transaction. RS Group ApS subsequently transferred all of its shares to RS Biopharma ApS, an entity controlled by Mr. Sindlev.